- Home
- Publications
- Publication Search
- Publication Details
Title
IDO2 in Immunomodulation and Autoimmune Disease
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-11-20
DOI
10.3389/fimmu.2014.00585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1
- (2014) Georgios Pantouris et al. AMINO ACIDS
- Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
- (2014) George C. Prendergast et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
- (2014) Richard Metz et al. INTERNATIONAL IMMUNOLOGY
- The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells
- (2014) S. Trabanelli et al. JOURNAL OF IMMUNOLOGY
- IDO2 Is a Critical Mediator of Autoantibody Production and Inflammatory Pathogenesis in a Mouse Model of Autoimmune Arthritis
- (2014) L. M. F. Merlo et al. JOURNAL OF IMMUNOLOGY
- Who knows why regulatory T cells are defective in RA ... IDO
- (2014) Nicholas J. Bernard Nature Reviews Rheumatology
- Treg Cell Function in Rheumatoid Arthritis Is Compromised by CTLA-4 Promoter Methylation Resulting in a Failure to Activate the Indoleamine 2,3-Dioxygenase Pathway
- (2014) Adam P. Cribbs et al. Arthritis & Rheumatology
- Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease
- (2013) Amos A. Fatokun et al. AMINO ACIDS
- Self-reactive T cells: suppressing the suppressors
- (2013) Jürgen C. Becker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Indoleamine 2,3-dioxygenases with very low catalytic activity are well conserved across kingdoms: IDOs of Basidiomycota
- (2013) Hajime J. Yuasa et al. FUNGAL GENETICS AND BIOLOGY
- Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2
- (2012) Supun M. Bakmiwewa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation
- (2012) Feng Qian et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases
- (2012) G. C. Prendergast et al. CURRENT MEDICINAL CHEMISTRY
- Studies on Tissue and Cellular Distribution of Indoleamine 2,3-Dioxygenase 2
- (2012) Masakazu Fukunaga et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder
- (2012) Jessica A Cutler et al. JOURNAL OF PSYCHOPHARMACOLOGY
- IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development
- (2012) Courtney Smith et al. Cancer Discovery
- Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses
- (2012) Tania Køllgaard et al. OncoImmunology
- IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
- (2012) Richard Metz et al. OncoImmunology
- Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors
- (2011) David Meininger et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes
- (2011) B.K.K. Lo et al. BRITISH JOURNAL OF DERMATOLOGY
- Spontaneous Cytotoxic T-Cell Reactivity against Indoleamine 2,3-Dioxygenase-2
- (2011) R. B. Sorensen et al. CANCER RESEARCH
- Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study
- (2011) Janette Furuzawa-Carballeda et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2
- (2010) Christopher Jonathan Daraius Austin et al. AMINO ACIDS
- Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
- (2010) X. Liu et al. BLOOD
- Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators
- (2010) R. B. Sorensen et al. BLOOD
- 1-l-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-d-methyltryptophan
- (2010) Hajime J. Yuasa et al. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
- Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells
- (2010) Ting Sun et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Consequences of AhR Activation in Steady-State Dendritic Cells
- (2010) T. Simones et al. TOXICOLOGICAL SCIENCES
- Functional and phenotypic effects of AhR activation in inflammatory dendritic cells
- (2010) Jaishree Bankoti et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes
- (2009) M. D. Sharma et al. BLOOD
- A Novel Cancer Therapy by Skin Delivery of Indoleamine 2,3-Dioxygenase siRNA
- (2009) M.-C. Yen et al. CLINICAL CANCER RESEARCH
- Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases
- (2009) Hajime J. Yuasa et al. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
- The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity
- (2009) G. N. Scott et al. JOURNAL OF IMMUNOLOGY
- Langerhans Cell Maturation and Contact Hypersensitivity Are Impaired in Aryl Hydrocarbon Receptor-Null Mice
- (2009) B. Jux et al. JOURNAL OF IMMUNOLOGY
- IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
- (2009) B. Baban et al. JOURNAL OF IMMUNOLOGY
- Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target
- (2009) Agnieszka K. Witkiewicz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase
- (2008) Christoph F.A. Vogel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
- (2008) Stefan Löb et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Expression of Indoleamine 2,3-Dioxygenase in Metastatic Pancreatic Ductal Adenocarcinoma Recruits Regulatory T Cells to Avoid Immune Detection
- (2008) Agnes Witkiewicz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase
- (2008) A. J. Muller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search